The Latest Clinical Advances in Thrombocytopenia 

<br/><br/><br/>English[eng] 
<br/><br/><label>ISBN: </label>9783040000000 
<br/><br/><label>Subjects--Topical Terms: </label><br/>thrombotic thrombocytopenic purpura||depression||resilience||quality of life||inherited thrombocytopenias||platelets||bleeding||TTP||ADAMTS13||treatment||diagnosis||follow-up||review||caplacizumab||pseudothrombocytopenia||hematimetry||fluorescence||amikacin||anticoagulants||COVID-19||platelet||thrombocytopenia||cardiac surgery||inflammation||biological prosthesis||extracorporeal life support||heparin-induced thrombocytopenia (HIT)||new concepts||pathogenesis||management||immune PF4/heparin/antibody complexes||Bayesian diagnostic thinking||therapeutic plasma exchange||intravenous immunoglobulins (IVIG)||immune thrombocytopenia||platelet destruction||immune tolerance||megakaryocytes||ITP treatment||virus infection||thrombocytopathy||aggregation||HIV||SARS-CoV-2||hantavirus||coronavirus||influenza||platelet disorders||procoagulant platelets||activation endpoints||myelodysplastic syndromes (MDS)||bone marrow failure (BMF) syndromes||aplastic anemia (AA)||next-generation sequencing (NGS)||platelet function tests||platelet count||flow cytometry||anticoagulation||antifibrinolytic||antiplatelet||cancer||thrombopoietin receptor agonist||tranexamic acid||advanced liver disease||bleeding risk||cirrhosis||hemostasis||thrombopoietin receptor agonists/mimetics||platelet transfusion guidelines||platelet transfusion alternatives||platelet additive solutions||platelet pathogen inactivation/reduction||cold stored platelet concentrates||n/a